December 29, 2011 — Medrad Inc. recently released the Certegra Informatics Connect.RIS vendor-neutral informatics application. The system establishes connectivity between Medrad's Stellant contrast-injection systems, and hospital radiology reporting systems and radiology information systems (RIS).  

The Connect.RIS application auto-populates contrast-injection records into radiology reporting systems and RIS, eliminating the need for radiologists to look-up or dictate contrast-injection records. In addition, the application delivers consistent patient records throughout facilities, and supports accurate and efficient billing and reconciliation processes.

Connect.RIS is part of the Certegra informatics platform, Medrad’s Contrast Dose Management solution. Certegra is comprised of a comprehensive line of products designed to support radiology professionals' clinical and administrative needs. The applications automatically document and integrate computed tomography (CT) contrast-injection records across clinical systems – using the injector as the source. Injector-based P3T software individualizes contrast protocols at the point-of-care. Certegra products work in any combination with Medrad's Stellant contrast-injection systems.

Additional Certegra software and applications include:

  • Manage.Report Application (data-driven reporting and analysis across CT suites and shifts):
    • Continually measures and helps radiology professionals actively manage performance department-wide
    • Helps to identify and uncover root cause of atypical events, re-scans and more
  • Connect.PACS application (PACS integration):
    • Automatically captures and integrates CT contrast-injection records (including the protocols programmed and delivered) into picture archiving and communications systems (PACS)
    • Provides radiologists new information concerning the contrast-injections associated with clinical images as they read
    • Allows radiologists to relate their evaluation of clinical images to any changes made at the point-of-care to the protocol prescribed
  • P3T software line (personalized CT contrast protocols for abdomen, cardiac and pulmonary angiography studies):
    • Enables consistent protocol optimization across patient populations and simplifies complex study administration
    • Enables a higher percentage of diagnostic studies and reduces the potential for unnecessary rescans

For more information: www.medrad.com


Related Content

News | Artificial Intelligence

May 14, 2025 – Bialogics Analytics Inc., a leader in radiology informatics, has introduced its new AI solution AI ...

Time May 16, 2025
arrow
News | Artificial Intelligence

May 6, 2025 — NewVue.ai, a leader in cloud-native radiology workflow orchestration, and MD.ai, a pioneer in AI-enhanced ...

Time May 06, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | SIIM

April 14, 2025 —The Society for Imaging Informatics in Medicine (SIIM) Annual Meeting is set to take place May 23 to 25 ...

Time April 14, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Artificial Intelligence

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 ...

Time February 04, 2025
arrow
News | Artificial Intelligence

Dec. 12, 2024 — At RSNA 2024, Careverse officially made its debut, exhibiting in the AI Showcase area, sharing its ...

Time December 18, 2024
arrow
News | Artificial Intelligence

Dec. 17, 2024 — Radin Health, a provider of advanced radiology AI-Powered solutions, highlighted its All-in-One ...

Time December 18, 2024
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
Subscribe Now